Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621816 · ClinicalTrials.gov registry record · Phase 2
Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)
A Phase 2 study of Hypertension, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
- 8
- Study locations
NCT00621816 is a Phase 2 study of Hypertension that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 45 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT00621816, a Phase 2 study of Hypertension, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
- 8
- Study locations
Study Summary
Nitroprusside is used commonly in the Intensive Care Unit for long periods of time in order to reduce blood pressure. It is not known if the body compensates over time to the blood pressure lowering, and if when the nitroprusside is stopped the blood pressure goes up at a faster rate and is higher than it was at the start of the treatment. This study will answer these questions.
Conditions Studied
Interventions
- DRUG nitroprusside
- DRUG placebo infusion
Study Locations (8)
North Carolina
- University of North Carolina - Chapel Hill - Chapel Hill
- Duke University Medical Center - Durham
- Duke University Medical Center - Durham
Arkansas
- Arkansas Children's Hospital - Little Rock
California
- Stanford University School of Medicine - Stanford
Kentucky
- Kosair Charities Pediatric Clinical Research Unit - Louisville
Michigan
- University of Michigan - Mott Children's Hospital - Ann Arbor
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-01 |
| Phase | Phase 2 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00621816
The ClinicalTrials.gov registry entry for NCT00621816 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which nitroprusside is the first listed.
NCT00621816 reports 8 study locations spanning 6 distinct geographic areas - top geographies include North Carolina, Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT00621816 about?
NCT00621816 is a clinical study titled "Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)". Nitroprusside is used commonly in the Intensive Care Unit for long periods of time in order to reduce blood pressure. It is not known if the body compensates over time to the blood pressure lowering, and if when the nitroprusside is stopped the blood pressure goes up at a faster rate and is higher t...
What is the current status of trial NCT00621816?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2009-01. Estimated completion is 2011-01.
What conditions does trial NCT00621816 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT00621816?
The interventions under investigation include: nitroprusside (DRUG), placebo infusion (DRUG).
Who is sponsoring clinical trial NCT00621816?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00621816 being conducted?
This trial has 8 study locations across Arkansas, California, Kentucky, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
RECRUITING · Phase 2
-
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
RECRUITING · Phase 2
-
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
RECRUITING · Phase 2
-
Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
RECRUITING · Phase 2
-
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
RECRUITING · Phase 2
-
Virtual Diabetes Group Visits Across Health Systems
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.